K Krzyzanowska, W Krugluger, F Mittermayer, R … - Clinical Science, 2006 - clinsci.org The recently discovered adipocytokine visfatin has insulin-like properties. It lowers blood glucose
and improves insulin sensitivity; however, clinical data on visfatin are limited. To evaluate the
role of visfatin in GDM (gestational diabetes mellitus), we determined visfatin levels in ... Cited by 91 - Related articles - Cached - BL Direct - All 10 versions
- ►endojournals.org CS Mantzoros, T Li, JAE Manson, JB Meigs, … - Journal of Clinical …, 2005 - Endocrine Soc Results: Circulating adiponectin levels were significantly and positively associated with
high-density lipoprotein (HDL) cholesterol and physical activity levels, and inversely with body
mass index and plasma concentrations of hemoglobin A 1c (HgbA 1c ), triglycerides, non- ... Cited by 58 - Related articles - BL Direct - All 6 versions
- ►mountsinai.on.ca [PDF] R Retnakaran, AJG Hanley, N Raif, CR Hirning, PW … - Diabetologia, 2005 - Springer Abstract Aims/hypothesis: Gestational diabetes mellitus (GDM) identifies a population of young
women at high risk of developing type 2 diabetes and thus provides an excellent model for studying
early events in the natural history of this disease. Adiponectin, a novel adipocyte-de- rived ... Cited by 56 - Related articles - All 6 versions
- ►endojournals.org SM Heitritter, CG Solomon, GF Mitchell, N Skali- … - Journal of Clinical …, 2005 - Endocrine Soc Context: A history of gestational diabetes (GDM) significantly increases the risk of developing
type 2 diabetes, an independent risk factor for cardiovascular disease (CVD). It is not known
whether nondiabetic women with prior GDM are also at increased risk of CVD. Cited by 44 - Related articles - BL Direct - All 5 versions
- ►darkmay.cz [PDF] DR Gable, SJ Hurel, SE Humphries - Atherosclerosis, 2006 - Elsevier The increasing prevalence of obesity and metabolic syndrome/insulin resistance has attracted
considerable interest due to their identification as risk factors for cardiovascular disease and,
hence, targets for cardiovascular disease prevention. This review focuses on adiponectin, ... Cited by 41 - Related articles - All 15 versions
K Matsushita, H Yatsuya, K Tamakoshi, K Wada, R … - Atherosclerosis, 2006 - Elsevier A population of 2347 middle-aged Japanese men with no medical history of cardiovascular
disease, cancer, diabetes, hypertension, or hyperlipidemia was evaluated. Those with some
metabolic syndrome components from serological and anthropometric tests were ... Cited by 29 - Related articles - All 9 versions
F Halperin, JA Beckman, ME Patti, ME Trujillo, M … - Diabetologia, 2005 - Springer Abstract Aims/hypothesis: Adiponectin is an adipokine with insulin-sensitising and anti-atherogenic
properties. We studied the role played by total adiponectin and by the bioactive
high-molecular-weight (HMW) oligomeric com- plexes of adiponectin in vascular function ... Cited by 29 - Related articles - BL Direct - All 3 versions
T Forst, C Hohberg, SD Fuellert, G Lübben, T … - Hormone and metabolic …, 2005 - cat.inist.fr The role of intact proinsulin and adiponectin in endothelial dysfunction and insulin resistance
has been receiving increasing attention. This study investigates the effect of PPARγ stimulation
or beta-cell stimulation on metabolic and vascular parameters in patients with type 2 ... Cited by 25 - Related articles - BL Direct - All 3 versions
- ►ccf.org [PDF] LA Barbour, CE McCurdy, TL Hernandez, JP … - Diabetes Care, 2007 - Am Diabetes Assoc The incidence of gestational diabetes mellitus (GDM) has doubled over the last 6–8 years and
is paralleling the obesity epidemic. GDM carries long-term implications for the subsequent development
of type 2 diabetes in the mother and increased risk for obesity and glucose intolerance in ... Cited by 26 - Related articles - BL Direct - All 13 versions
BB Duncan, MI Schmidt - Diabetes Technology & Therapeutics, 2006 - liebertonline.com The fattening of the human species and the accompanying emergence of the metabolic syn-
drome and of type 2 diabetes as remarkably frequent clinical entities are among the major
epi- demiologic events of our time. Control of the diabetes epidemic requires a greater ... Cited by 21 - Related articles - BL Direct - All 3 versions
